Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study

J. Bourhis; X. Sun; Y. Pointreau; C. Sire; C. Le Tourneau; Alexandre Coutte; M-C. Kaminsky-Forrett; M. Alfonsi; P. Boisselier; L. Martin; J-P. Delord; F. Clatot; J. Miroir; F. Rolland; P. Crompton; S. Brienza; S. A. Szyldergemajn; C. Even; Y. Tao

Article dans une revue

Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study

Type de document :

Article dans une revue

Domaine :

Sciences du Vivant [q-bio]

Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03600473
Contributeur : Louise DESSAIVRE Connectez-vous pour contacter le contributeur
Soumis le : lundi 7 mars 2022 - 15:41:37
Dernière modification le : vendredi 2 septembre 2022 - 18:08:25

Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study

Identifiants

Collections

Citation

Exporter

Métriques

3

Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study

Identifiants

Collections

Citation

Exporter

Partager

Métriques

3